Tatva Chintan Pharma, a chemical manufacturing company is coming out with an IPO on July 16 with a Price band of Rs.1073 to 1083 per equity share.
Tatva Chintan Pharma Chem Limited is a chemical manufacturing company that manufactures structure directing agents (SDAs), phase transfer catalyst (PTCs), pharmaceutical and agrochemical intermediates, and other specialty chemicals. It is among the largest manufacturer of SDAs for zeolites in India.
The company serves customers across industries i.e. automotive, petroleum, agrochemicals, dyes and pigments, paints and coatings, pharmaceutical, personal care, and others. Its products are not only sold in India but also export to 25+ countries all over the world such as the USA, Germany, South Africa, China, and the UK. In FY 2020, total export contributed to 76% of total revenue from operations.
Merck, Bayer AG, Ipox Chemicals, Laurus labs, Navin Fluorine International Limited, Atul Limited, Otsuka Chemicals, SRF Limited, Hawks Chemical Company, Firmenich Aromatics Prod Pvt Ltd, and Divi’s laboratories are a few of customers of the company. Currently, it has two manufacturing facilities at Ankleshwar and Dahej in Gujarat.
Financials
| Particulars | For the year/period ended (₹ in million) | ||||
|---|---|---|---|---|---|
| 31-Mar-21 | 31-Mar-20 | 31-Mar-19 | |||
| Total Assets | 3,148.03 | 2,489.38 | 1,875.08 | ||
| Total Revenue | 3,062.92 | 2,646.22 | 2,068.01 | ||
| Profit After Tax | 522.62 | 377.89 | 205.43 | ||
Important Information about Tatva Chintan Pharma Chem IPO
| IPO Opening Date | Jul 16, 2021 |
| IPO Closing Date | Jul 20, 2021 |
| Issue Type | Book Built Issue IPO |
| Face Value | ₹10 per equity share |
| IPO Price | ₹1073 to ₹1083 per equity share |
| Market Lot | 13 Shares |
| Min Order Quantity | 13 Shares |
| Listing At | BSE, NSE |
Important Dates about Tatva Chintan Pharma Chem IPO
| IPO Open Date | Jul 16, 2021 |
| IPO Close Date | Jul 20, 2021 |
| Basis of Allotment Date | Jul 26, 2021 |
| Initiation of Refunds | Jul 27, 2021 |
| Credit of Shares to Demat Account | Jul 28, 2021 |
| IPO Listing Date | Jul 29, 2021 |
